Skip to content
10-K

Annual Report

Turn Therapeutics Inc. TTRX

0001213900-26-037505

← back to feed
Filed
Mar 31, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 30, 2026 29.79M sh
Shares Diluted FY 2025 · Dec 31, 2025 27.72M sh
Shares Diluted FY 2025 · Dec 31, 2024 26.64M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$2.56M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$1.36M
Cash And Equivalents FY 2025 · Dec 31, 2025 $4.03M
Cash And Equivalents FY 2025 · Dec 31, 2024 $498.29K
Stockholders Equity FY 2025 · Dec 31, 2025 $4.69M
Stockholders Equity FY 2025 · Dec 31, 2024 −$177.43K
Stockholders Equity FY 2025 · Dec 31, 2023 $85.77K
Current Liabilities FY 2025 · Dec 31, 2025 $6M
Current Liabilities FY 2025 · Dec 31, 2024 $707.93K
Total Liabilities FY 2025 · Dec 31, 2025 $7.48M
Total Liabilities FY 2025 · Dec 31, 2024 $2.23M
Current Assets FY 2025 · Dec 31, 2025 $5.2M
Current Assets FY 2025 · Dec 31, 2024 $1.1M
Total Assets FY 2025 · Dec 31, 2025 $12.16M
Total Assets FY 2025 · Dec 31, 2024 $2.05M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.12
Eps Diluted FY 2025 · Dec 31, 2024 −$0.07
Eps Basic FY 2025 · Dec 31, 2025 −$0.12
Eps Basic FY 2025 · Dec 31, 2024 −$0.07
Sga Expense FY 2025 · Dec 31, 2025 $5.59M
Sga Expense FY 2025 · Dec 31, 2024 $1.55M
Rd Expense FY 2025 · Dec 31, 2025 $265.57K
Rd Expense FY 2025 · Dec 31, 2024 $245.96K
Net Income FY 2025 · Dec 31, 2025 −$3.19M
Net Income FY 2025 · Dec 31, 2024 −$1.77M
Operating Income FY 2025 · Dec 31, 2025 −$5.86M
Operating Income FY 2025 · Dec 31, 2024 −$1.8M